Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-05-21 @ 11:16 PM
Study NCT ID:
NCT01049867
Status:
UNKNOWN
Last Update Posted:
2010-01-15
First Post:
2010-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD133+ Cell Therapy for Refractory Coronary Heart Disease
Sponsor:
Hospital y Clinica OCA, S.A. de C.V.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASOR01CMN093300CT051044-1895
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Genaro Levinson/Director
Old Organization:
Hospital y Clinica OCA, S.A. de C.V.